Departamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain.
Chemistry. 2011 Dec 9;17(50):14074-83. doi: 10.1002/chem.201101547. Epub 2011 Nov 9.
Synthetic prodiginine obatoclax shows promise as a potential anticancer drug. This compound promotes apoptosis of cancer cells, although the mechanism of action is unclear. To date, only the inhibition of BCL-2 proteins has been proposed as a mechanism of action. To gain insight into other possible modes of action, we have studied the anion-binding properties of obatoclax and related analogues in solution, in the solid state, and by means of density functional theory calculations. These compounds are well suited to interact with anions such as chloride and bicarbonate. The anion-transport properties of the compounds synthesized were assayed in model phospholipid liposomes by using a chloride-selective-electrode technique and (13)C NMR spectroscopy. The results demonstrated that these compounds are efficient anion exchangers that promote chloride, bicarbonate, and nitrate transport through lipid bilayers at very low concentrations. In vitro studies on small-cell lung carcinoma cell line GLC4 showed that active ionophores are able to discharge pH gradients in living cells and the cytotoxicity of these compounds correlates well with ionophoric activity.
合成的原二聚素 obatoclax 有望成为一种潜在的抗癌药物。这种化合物能促进癌细胞凋亡,但其作用机制尚不清楚。迄今为止,仅提出抑制 BCL-2 蛋白作为一种作用机制。为了深入了解其他可能的作用模式,我们研究了 obatoclax 及其相关类似物在溶液、固态和通过密度泛函理论计算中的阴离子结合特性。这些化合物非常适合与氯离子和碳酸氢根等阴离子相互作用。通过使用氯离子选择性电极技术和 (13)C NMR 光谱法,在模型磷脂脂质体中测定了合成化合物的阴离子转运特性。结果表明,这些化合物是有效的阴离子交换剂,能够在非常低的浓度下促进氯离子、碳酸氢根和硝酸根通过脂质双层的转运。在小细胞肺癌细胞系 GLC4 的体外研究中,活性离子载体能够在活细胞中排出 pH 梯度,并且这些化合物的细胞毒性与离子载体活性很好地相关。